NCT02897765 2021-02-25A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder CancerBioNTech SEPhase 1 Completed34 enrolled
NCT01079741 2018-02-13Safety Study of Adjuvant Vaccine to Treat Melanoma PatientsIcahn School of Medicine at Mount SinaiPhase 1/2 Completed34 enrolled 10 charts